CAST

108.75

+0.88%↑

PNDX.B

178.6

+1.25%↑

WALL.B

40.74

+0.39%↑

SAGAD

33.65

+0.45%↑

119.3

+1.45%↑

CAST

108.75

+0.88%↑

PNDX.B

178.6

+1.25%↑

WALL.B

40.74

+0.39%↑

SAGAD

33.65

+0.45%↑

119.3

+1.45%↑

CAST

108.75

+0.88%↑

PNDX.B

178.6

+1.25%↑

WALL.B

40.74

+0.39%↑

SAGAD

33.65

+0.45%↑

119.3

+1.45%↑

CAST

108.75

+0.88%↑

PNDX.B

178.6

+1.25%↑

WALL.B

40.74

+0.39%↑

SAGAD

33.65

+0.45%↑

119.3

+1.45%↑

CAST

108.75

+0.88%↑

PNDX.B

178.6

+1.25%↑

WALL.B

40.74

+0.39%↑

SAGAD

33.65

+0.45%↑

119.3

+1.45%↑

Kodu・Aktsiate loetelu・Indutrade AB

Indutrade AB

Suletud

213.6 1.14

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

210.4

Max

215.2

Põhinäitajad
By Trading Economics
Sissetulek	244M 918M
Müük	380M 8.2B
P/E Sektori keskmine	29.957 65.714
Aktsiakasum	1.72
Dividenditootlus	1.51
Kasumimarginaal	11.16
Töötajad	9,850
EBITDA	-44M 1.4B

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.51% 6.83%
Järgmine tulemuste avaldamine	24. apr 2026

Turustatistika
By TradingEconomics
Turukapital	-5.3B 77B
Eelmine avamishind	212.46
Eelmine sulgemishind	213.6

Indutrade AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. märts 2026, 23:31 UTC

Kuumad aktsiad

Stocks to Watch: Nike, RH, NCino

31. märts 2026, 22:35 UTC

Tulu

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. apr 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. märts 2026, 23:50 UTC

Omandamised, ülevõtmised, äriostud

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. märts 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. märts 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. märts 2026, 23:21 UTC

Tulu

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. märts 2026, 23:14 UTC

Market Talk

Tulu

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. märts 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss Widens >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. märts 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. märts 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. märts 2026, 21:35 UTC

Tulu

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. märts 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. märts 2026, 21:33 UTC

Tulu

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. märts 2026, 21:32 UTC

Tulu

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. märts 2026, 21:28 UTC

Tulu

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. märts 2026, 21:26 UTC

Tulu

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. märts 2026, 21:25 UTC

Tulu

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. märts 2026, 21:24 UTC

Market Talk

Tulu

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. märts 2026, 21:22 UTC

Tulu

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. märts 2026, 21:22 UTC

Tulu

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. märts 2026, 21:21 UTC

Tulu

Nike's Digital Channel Still Too Promotional, CFO Says

31. märts 2026, 21:20 UTC

Tulu

Nike CEO: Converse Remains Important to Portfolio

Võrdlus sarnastega

Hinnamuutus

Indutrade AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Indutrade AB

Indutrade AB (publ) manufactures, develops, and sells components, systems, and services to various industries worldwide. It operates through Benelux, DACH, Finland, Flow Technology, Fluids & Mechanical Solutions, Industrial Components, Measurement & Sensor Technology, and UK segments. The company provides components and systems for controlling, measuring, monitoring, and regulating flows, as well as for industrial production and maintenance; medical technology equipment; measurement instruments and systems, sensors, control and regulating technology, and monitoring equipment; and custom-manufactured products, design solutions, aftermarket and assembly services, and customization services. In addition, it provides valves, hydraulic and industrial equipment, measurement technology, construction materials, filters, pipes and pipe systems, auto repair, tools and transmission, industrial springs, water and wastewater, lighting, chemical technology, fasteners, electronics, vehicles, energy, springs, piston rings, press work, and valve channels. Indutrade AB (publ) was incorporated in 1919 and is based in Kista, Sweden.